CD4 and malignant glioma: Current studies demonstrate that regulatory T cells within malignant gliomas also suppress pro-inflammatory cytokine production (TNF-a, IFN-γ, and IL-6) and impair antigen presentation by monocytes and macrophages in a process that is distinct from their inhibition of effector CD4 and CD8 T-cell activity.